Rubic One Health

RUBIC One Health Collaborates with South Africa’s Leading Scientists to Develop an Innovative Approach for Developing, Testing, and Scaling the Production of Vaccines for Humans and Animals Against COVID-19. Local production and innovative methods will ensure sufficient quantities and low-cost vaccines for the African market. The new technology used can be further extended to treatments for both human and veterinary markets.